Advanced search
Publication Cover
Acta Oncologica Volume 50, 2011 - Issue 3
Journal homepage
990
Views
32
CrossRef citations to date
0
Altmetric
Letter

Use of interferon-alpha in two patients with Merkel cell carcinoma positive for Merkel cell polyomavirus

Caroline Biver-Dalle Université de Franche Comté, EA3181, IFR133, Besançon, France; Centre Hospitalier Universitaire, Service de Dermatologie, Besançon, France
,
Thierry Nguyen Centre Hospitalier Universitaire, Service d'Oncologie, Besançon, France
,
Antoine Touzé Université F. Rabelais, INSERM U618, Tours, France
,
Clarisse Saccomani Université de Franche Comté, EA3181, IFR133, Besançon, France; Centre Hospitalier Universitaire, Service de Dermatologie, Besançon, France
,
Séverine Penz Université de Franche Comté, EA3181, IFR133, Besançon, France; Centre Hospitalier Universitaire, Service de Dermatologie, Besançon, France
,
Sandrine Cunat-Peultier Université de Franche Comté, EA3181, IFR133, Besançon, France; Centre Hospitalier Universitaire, Service de Dermatologie, Besançon, France
,
Marie-Odile Riou-Gotta Université de Franche Comté, EA3181, IFR133, Besançon, France; Centre Hospitalier Universitaire, Service de Dermatologie, Besançon, France
,
Philippe Humbert Centre Hospitalier Universitaire, Service de Dermatologie, Besançon, France
,
Pierre Coursaget Université F. Rabelais, INSERM U618, Tours, France
&
François Aubin Université de Franche Comté, EA3181, IFR133, Besançon, France; Centre Hospitalier Universitaire, Service de Dermatologie, Besançon, FranceCorrespondence[email protected]
 show all
Pages 479-480 | Received 08 Jun 2010, Accepted 29 Jul 2010, Published online: 09 Sep 2010

Citations (32)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Alok T Saini & Brett A Miles. (2015) Merkel cell carcinoma of the head and neck: pathogenesis, current and emerging treatment options. OncoTargets and Therapy 8, pages 2157-2167.
Read now
Rafal Matkowski, Ewelina Lata, Marcin Zietek, Agnieszka Halon, Jozef Forgacz & Bartlomiej Szynglarewicz. (2014) Multidisciplinary management in Merkel cell carcinoma. Journal of Dermatological Treatment 25:5, pages 409-414.
Read now

Articles from other publishers (30)

Beatriz Vieira Neto, Valéria Tavares, Joana M. O. Santos, Fátima Cerqueira, Deolinda Pereira & Rui Medeiros. (2023) Map of thrombogenesis in viral infections and viral-driven tumours. Discover Oncology 14:1.
Crossref
Wei-Liang Shih, Chi-Tai Fang & Pei-Jer Chen. 2021. Viruses and Human Cancer. Viruses and Human Cancer 325 354 .
Christine Cornejo & Christopher J. Miller. (2019) Merkel Cell Carcinoma. Dermatologic Clinics 37:3, pages 269-277.
Crossref
Mahtab Samimi. (2019) Immune Checkpoint Inhibitors and Beyond: An Overview of Immune-Based Therapies in Merkel Cell Carcinoma. American Journal of Clinical Dermatology 20:3, pages 391-407.
Crossref
Pauline Tétu, Barouyr Baroudjian, Isabelle Madelaine, Julie Delyon & Céleste Lebbé. (2019) Avancées thérapeutiques récentes dans la prise en charge du carcinome à cellules de Merkel. Bulletin du Cancer 106:1, pages 64-72.
Crossref
Kotaro Nagase & Yutaka Narisawa. (2018) Immunotherapy for Merkel Cell Carcinoma. Current Treatment Options in Oncology 19:11.
Crossref
Gabrielė Stakaitytė, Nnenna Nwogu, Samuel J. Dobson, Laura M. Knight, Christopher W. Wasson, Francisco J. Salguero, David J. Blackbourn, G. Eric Blair, Jamel Mankouri, Andrew Macdonald & Adrian Whitehouse. (2018) Merkel Cell Polyomavirus Small T Antigen Drives Cell Motility via Rho-GTPase-Induced Filopodium Formation. Journal of Virology 92:2.
Crossref
Paul Nghiem, Howard L Kaufman, Murtuza Bharmal, Lisa Mahnke, Hemant Phatak & Jürgen C Becker. (2017) Systematic literature review of efficacy, safety and tolerability outcomes of chemotherapy regimens in patients with metastatic Merkel cell carcinoma. Future Oncology 13:14, pages 1263-1279.
Crossref
Cathrin Ritter, Kaiji Fan, Annette Paschen, Sine Reker Hardrup, Soldano Ferrone, Paul Nghiem, Selma Ugurel, David Schrama & Jürgen C. Becker. (2017) Epigenetic priming restores the HLA class-I antigen processing machinery expression in Merkel cell carcinoma. Scientific Reports 7:1.
Crossref
Meghana Anika Varde. 2017. Emergencies of the Orbit and Adnexa. Emergencies of the Orbit and Adnexa 439 444 .
Brett A. Miles & David Goldenberg. (2016) Merkel cell carcinoma: Do you know your guidelines?. Head & Neck 38:5, pages 647-652.
Crossref
Ugo Moens, Kashif Rasheed, Ibrahim Abdulsalam & Baldur Sveinbjørnsson. (2015) The Role of Merkel Cell Polyomavirus and Other Human Polyomaviruses in Emerging Hallmarks of Cancer. Viruses 7:4, pages 1871-1901.
Crossref
Mahtab Samimi, Charlotte Gardair, Jérome T.J. Nicol, Francoise Arnold, Antoine Touzé & Pierre Coursaget. (2015) Merkel Cell Polyomavirus in Merkel Cell Carcinoma: Clinical and Therapeutic Perspectives. Seminars in Oncology 42:2, pages 347-358.
Crossref
Kathryn Serowka, Sarah Arron & Siegrid S. Yu. 2015. Advances in Transplant Dermatology. Advances in Transplant Dermatology 99 110 .
Kelly G. Paulson, Andrew Tegeder, Christoph Willmes, Jayasri G. Iyer, Olga K. Afanasiev, David Schrama, Shinichi Koba, Renee Thibodeau, Kotaro Nagase, William T. Simonson, Aaron Seo, David M. Koelle, Margaret Madeleine, Shailender Bhatia, Hideki Nakajima, Shigetoshi Sano, James S. Hardwick, Mary L. Disis, Michele A. Cleary, Jürgen C. Becker & Paul Nghiem. (2014) Downregulation of MHC-I Expression Is Prevalent but Reversible in Merkel Cell Carcinoma. Cancer Immunology Research 2:11, pages 1071-1079.
Crossref
F. Kleffner, J. Schürholz, S. Burckhardt, C. Mauch & M. Schlaak. (2014) Merkel-Zell-KarzinomMerkel cell carcinoma. Der Hautarzt 65:9, pages 823-832.
Crossref
Piotr Czapiewski & Wojciech Biernat. (2014) Merkel cell carcinoma – Recent advances in the biology, diagnostics and treatment. The International Journal of Biochemistry & Cell Biology 53, pages 536-546.
Crossref
Janice Ma & Jerry Brewer. (2014) Merkel Cell Carcinoma in Immunosuppressed Patients. Cancers 6:3, pages 1328-1350.
Crossref
Gabrielė Stakaitytė, Jennifer Wood, Laura Knight, Hussein Abdul-Sada, Noor Adzahar, Nnenna Nwogu, Andrew Macdonald & Adrian Whitehouse. (2014) Merkel Cell Polyomavirus: Molecular Insights into the Most Recently Discovered Human Tumour Virus. Cancers 6:3, pages 1267-1297.
Crossref
Wei-Liang Shih, Chi-Tai Fang & Pei-Jer Chen. 2014. Viruses and Human Cancer. Viruses and Human Cancer 269 290 .
Pierre Coursaget, Mahtab Samimi, Jérome T.J. Nicol, Charlotte Gardair & Antoine Touzé. (2013) Human Merkel cell polyomavirus: virological background and clinical implications. APMIS 121:8, pages 755-769.
Crossref
Natalie J. Miller, Shailender Bhatia, Upendra Parvathaneni, Jayasri G. Iyer & Paul Nghiem. (2013) Emerging and Mechanism-Based Therapies for Recurrent or Metastatic Merkel Cell Carcinoma. Current Treatment Options in Oncology 14:2, pages 249-263.
Crossref
Pierre Triozzi & Anthony Fernandez. (2013) The Role of the Immune Response in Merkel Cell Carcinoma. Cancers 5:4, pages 234-254.
Crossref
Laura Desch & Rainer Kunstfeld. (2013) Merkel Cell Carcinoma: Chemotherapy and Emerging New Therapeutic Options. Journal of Skin Cancer 2013, pages 1-9.
Crossref
Olga Afanasiev & Paul Nghiem. 2013. Merkel Cell Carcinoma. Merkel Cell Carcinoma 171 184 .
Sandra Y. Han, Jeffrey P. North, Theresa Canavan, Nancy Kim & Siegrid S. Yu. (2012) Merkel Cell Carcinoma. Hematology/Oncology Clinics of North America 26:6, pages 1351-1374.
Crossref
Christoph Willmes, Christian Adam, Miriam Alb, Lena Völkert, Roland Houben, Jürgen C. Becker & David Schrama. (2012) Type I and II IFNs Inhibit Merkel Cell Carcinoma via Modulation of the Merkel Cell Polyomavirus T Antigens. Cancer Research 72:8, pages 2120-2128.
Crossref
. (2012) Current World Literature. Current Opinion in Oncology 24:2, pages 197-202.
Crossref
David Schrama, Selma Ugurel & Jürgen C. Becker. (2012) Merkel cell carcinoma. Current Opinion in Oncology 24:2, pages 141-149.
Crossref
Ulrike Wieland & Alexander Kreuter. (2011) Merkel cell polyomavirus infection and Merkel cell carcinoma in HIV-positive individuals. Current Opinion in Oncology 23:5, pages 488-493.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.